Copyright Reports & Markets. All rights reserved.

Global Microbial Fermentation APIs Market Growth 2019-2024

Request for Sample of this report
Buy now

Table of Contents

    2019-2024 Global Microbial Fermentation APIs Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Microbial Fermentation APIs Consumption 2014-2024
        • 2.1.2 Microbial Fermentation APIs Consumption CAGR by Region
      • 2.2 Microbial Fermentation APIs Segment by Type
        • 2.2.1 Antibiotics
        • 2.2.2 Amino acids
        • 2.2.3 Vitamin
        • 2.2.4 Nucleotide
        • 2.2.5 Organic acid
        • 2.2.6 Alcohol
        • 2.2.7 Biological products
        • 2.2.8 Hormone
      • 2.3 Microbial Fermentation APIs Consumption by Type
        • 2.3.1 Global Microbial Fermentation APIs Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global Microbial Fermentation APIs Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global Microbial Fermentation APIs Sale Price by Type (2014-2019)
      • 2.4 Microbial Fermentation APIs Segment by Application
        • 2.4.1 Hospitals
        • 2.4.2 Research & Academic Laboratories
        • 2.4.3 Pharmaceutical & Biotechnology Companies
      • 2.5 Microbial Fermentation APIs Consumption by Application
        • 2.5.1 Global Microbial Fermentation APIs Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global Microbial Fermentation APIs Value and Market Share by Application (2014-2019)
        • 2.5.3 Global Microbial Fermentation APIs Sale Price by Application (2014-2019)

      3 Global Microbial Fermentation APIs by Players

      • 3.1 Global Microbial Fermentation APIs Sales Market Share by Players
        • 3.1.1 Global Microbial Fermentation APIs Sales by Players (2017-2019)
        • 3.1.2 Global Microbial Fermentation APIs Sales Market Share by Players (2017-2019)
      • 3.2 Global Microbial Fermentation APIs Revenue Market Share by Players
        • 3.2.1 Global Microbial Fermentation APIs Revenue by Players (2017-2019)
        • 3.2.2 Global Microbial Fermentation APIs Revenue Market Share by Players (2017-2019)
      • 3.3 Global Microbial Fermentation APIs Sale Price by Players
      • 3.4 Global Microbial Fermentation APIs Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global Microbial Fermentation APIs Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players Microbial Fermentation APIs Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Microbial Fermentation APIs by Regions

      • 4.1 Microbial Fermentation APIs by Regions
        • 4.1.1 Global Microbial Fermentation APIs Consumption by Regions
        • 4.1.2 Global Microbial Fermentation APIs Value by Regions
      • 4.2 Americas Microbial Fermentation APIs Consumption Growth
      • 4.3 APAC Microbial Fermentation APIs Consumption Growth
      • 4.4 Europe Microbial Fermentation APIs Consumption Growth
      • 4.5 Middle East & Africa Microbial Fermentation APIs Consumption Growth

      5 Americas

      • 5.1 Americas Microbial Fermentation APIs Consumption by Countries
        • 5.1.1 Americas Microbial Fermentation APIs Consumption by Countries (2014-2019)
        • 5.1.2 Americas Microbial Fermentation APIs Value by Countries (2014-2019)
      • 5.2 Americas Microbial Fermentation APIs Consumption by Type
      • 5.3 Americas Microbial Fermentation APIs Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Microbial Fermentation APIs Consumption by Countries
        • 6.1.1 APAC Microbial Fermentation APIs Consumption by Countries (2014-2019)
        • 6.1.2 APAC Microbial Fermentation APIs Value by Countries (2014-2019)
      • 6.2 APAC Microbial Fermentation APIs Consumption by Type
      • 6.3 APAC Microbial Fermentation APIs Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Microbial Fermentation APIs by Countries
        • 7.1.1 Europe Microbial Fermentation APIs Consumption by Countries (2014-2019)
        • 7.1.2 Europe Microbial Fermentation APIs Value by Countries (2014-2019)
      • 7.2 Europe Microbial Fermentation APIs Consumption by Type
      • 7.3 Europe Microbial Fermentation APIs Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Microbial Fermentation APIs by Countries
        • 8.1.1 Middle East & Africa Microbial Fermentation APIs Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa Microbial Fermentation APIs Value by Countries (2014-2019)
      • 8.2 Middle East & Africa Microbial Fermentation APIs Consumption by Type
      • 8.3 Middle East & Africa Microbial Fermentation APIs Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Channels
        • 10.1.2 Indirect Channels
      • 10.2 Microbial Fermentation APIs Distributors
      • 10.3 Microbial Fermentation APIs Customer

      11 Global Microbial Fermentation APIs Market Forecast

      • 11.1 Global Microbial Fermentation APIs Consumption Forecast (2019-2024)
      • 11.2 Global Microbial Fermentation APIs Forecast by Regions
        • 11.2.1 Global Microbial Fermentation APIs Forecast by Regions (2019-2024)
        • 11.2.2 Global Microbial Fermentation APIs Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Microbial Fermentation APIs Forecast by Type
      • 11.8 Global Microbial Fermentation APIs Forecast by Application

      12 Key Players Analysis

      • 12.1 Merck
        • 12.1.1 Company Details
        • 12.1.2 Microbial Fermentation APIs Product Offered
        • 12.1.3 Merck Microbial Fermentation APIs Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 Merck News
      • 12.2 Ajinomoto
        • 12.2.1 Company Details
        • 12.2.2 Microbial Fermentation APIs Product Offered
        • 12.2.3 Ajinomoto Microbial Fermentation APIs Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 Ajinomoto News
      • 12.3 HGPF
        • 12.3.1 Company Details
        • 12.3.2 Microbial Fermentation APIs Product Offered
        • 12.3.3 HGPF Microbial Fermentation APIs Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.3.4 Main Business Overview
        • 12.3.5 HGPF News
      • 12.4 Huaxing
        • 12.4.1 Company Details
        • 12.4.2 Microbial Fermentation APIs Product Offered
        • 12.4.3 Huaxing Microbial Fermentation APIs Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.4.4 Main Business Overview
        • 12.4.5 Huaxing News
      • 12.5 North China Pharmaceutical
        • 12.5.1 Company Details
        • 12.5.2 Microbial Fermentation APIs Product Offered
        • 12.5.3 North China Pharmaceutical Microbial Fermentation APIs Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.5.4 Main Business Overview
        • 12.5.5 North China Pharmaceutical News
      • 12.6 Topfond
        • 12.6.1 Company Details
        • 12.6.2 Microbial Fermentation APIs Product Offered
        • 12.6.3 Topfond Microbial Fermentation APIs Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.6.4 Main Business Overview
        • 12.6.5 Topfond News
      • 12.7 DSM
        • 12.7.1 Company Details
        • 12.7.2 Microbial Fermentation APIs Product Offered
        • 12.7.3 DSM Microbial Fermentation APIs Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.7.4 Main Business Overview
        • 12.7.5 DSM News
      • 12.8 Tianyao
        • 12.8.1 Company Details
        • 12.8.2 Microbial Fermentation APIs Product Offered
        • 12.8.3 Tianyao Microbial Fermentation APIs Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.8.4 Main Business Overview
        • 12.8.5 Tianyao News
      • 12.9 CSPC Pharma
        • 12.9.1 Company Details
        • 12.9.2 Microbial Fermentation APIs Product Offered
        • 12.9.3 CSPC Pharma Microbial Fermentation APIs Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.9.4 Main Business Overview
        • 12.9.5 CSPC Pharma News
      • 12.10 Northeast Pharm
        • 12.10.1 Company Details
        • 12.10.2 Microbial Fermentation APIs Product Offered
        • 12.10.3 Northeast Pharm Microbial Fermentation APIs Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.10.4 Main Business Overview
        • 12.10.5 Northeast Pharm News
      • 12.11 Lukang Pharmaceutical
      • 12.12 Luwei Pharmaceutical
      • 12.13 Jiangshan (DSM)

      13 Research Findings and Conclusion

      Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. They are generally manufactured through a variety of processes that include chemical synthesis, fermentation processes, recombinant DNA, etc.

      Microbial fermentation APIs are secondary metabolites produced by micro-organisms such as fungi and actinomycetes. The micro-organisms are capable of converting inexpensive carbon sources (starch, glucose, sucrose, etc.) and nitrogen sources (soybean flour, cotton-seed flour, peptone, etc.) into highly valuable API's or key intermediates (such as amino acids, vitamines, antibiotics) in liquid or solid media under certain growth conditions (nutrients, temperature, PH, oxygen supply).

      Microorganisms that are typically used within the pharmaceutical industry include: prokaryotes such as Bacteria (e.g. Escherichia coli, Staphylococcus aureus) and Streptomycetes (e.g. Streptomyces spp, Actinomyces spp), eukaryotes such as Filamentous Fungi (e.g., Nigrospora spp, Aspergillus spp,) and Yeast (e.g. Saccharomyces cereviciae, Pichia pastoris).

      With developed pharmaceuticals industry, Europe, USA and Japan are the major consumption markets of microbial fermentation APIs. These international pharmaceuticals giants generally purchase APIs from Asia, especially China and India.
      China is the emerging consumption market of microbial fermentation APIs and it is also the largest supplier. In the market of antibiotics and vitamin, China have occupied market share of more than half. With foreign based plants and local manufacturers, India is another major supplier of APIs.
      Antibiotics enjoyed the largest market share of microbial fermentation APIs, and China is the largest supplier with production of about 150 K MT. Amino acids are another important parts of microbial fermentation APIs market. Among these amino acids, the amount of glutamic acid and l-lysine are at most.

      According to this study, over the next five years the Microbial Fermentation APIs market will register a 1.8% CAGR in terms of revenue, the global market size will reach US$ 30800 million by 2024, from US$ 27700 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Microbial Fermentation APIs business, shared in Chapter 3.

      This report presents a comprehensive overview, market shares, and growth opportunities of Microbial Fermentation APIs market by product type, application, key manufacturers and key regions and countries.

      This study considers the Microbial Fermentation APIs value and volume generated from the sales of the following segments:

      Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
      Antibiotics
      Amino acids
      Vitamin
      Nucleotide
      Organic acid
      Alcohol
      Biological products
      Hormone
      Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
      Hospitals
      Research & Academic Laboratories
      Pharmaceutical & Biotechnology Companies

      This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
      Americas
      United States
      Canada
      Mexico
      Brazil
      APAC
      China
      Japan
      Korea
      Southeast Asia
      India
      Australia
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Middle East & Africa
      Egypt
      South Africa
      Israel
      Turkey
      GCC Countries

      The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
      Merck
      Ajinomoto
      HGPF
      Huaxing
      North China Pharmaceutical
      Topfond
      DSM
      Tianyao
      CSPC Pharma
      Northeast Pharm
      Lukang Pharmaceutical
      Luwei Pharmaceutical
      Jiangshan (DSM)

      In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

      Research objectives
      To study and analyze the global Microbial Fermentation APIs consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
      To understand the structure of Microbial Fermentation APIs market by identifying its various subsegments.
      Focuses on the key global Microbial Fermentation APIs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the Microbial Fermentation APIs with respect to individual growth trends, future prospects, and their contribution to the total market.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      To project the consumption of Microbial Fermentation APIs submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.

      Buy now